Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-12-23
pubmed:abstractText
Our goal was to identify candidate polymorphisms that could influence overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients treated with carboplatin (CBDCA) and paclitaxel (PTX).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1556-1380
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
132-8
pubmed:meshHeading
pubmed-meshheading:21079520-Adult, pubmed-meshheading:21079520-Aged, pubmed-meshheading:21079520-Aged, 80 and over, pubmed-meshheading:21079520-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21079520-Carboplatin, pubmed-meshheading:21079520-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:21079520-DNA, Neoplasm, pubmed-meshheading:21079520-Female, pubmed-meshheading:21079520-Genome-Wide Association Study, pubmed-meshheading:21079520-Humans, pubmed-meshheading:21079520-Lung Neoplasms, pubmed-meshheading:21079520-Male, pubmed-meshheading:21079520-Middle Aged, pubmed-meshheading:21079520-Neoplasm Staging, pubmed-meshheading:21079520-Paclitaxel, pubmed-meshheading:21079520-Pharmacogenetics, pubmed-meshheading:21079520-Polymerase Chain Reaction, pubmed-meshheading:21079520-Polymorphism, Single Nucleotide, pubmed-meshheading:21079520-Prognosis, pubmed-meshheading:21079520-Risk Factors, pubmed-meshheading:21079520-Survival Rate, pubmed-meshheading:21079520-Tissue Distribution
pubmed:year
2011
pubmed:articleTitle
Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.
pubmed:affiliation
Genetics Division, National Cancer Center Research Institute, Tokyo, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't